Table 1.
Comparison of clinical characteristics between IVIG-responsive and IVIG-resistant cases.
| Variable | Total (n = 282) | IVIG-responsive (n = 259) | IVIG-resistant (n = 23) | P-value |
|---|---|---|---|---|
| Gender (M/F) | 194/88 | 175/84 | 19/4 | 0.136 |
| Age, months | 7.00 (4.00, 9.00) | 7.00 (4.00, 9.00) | 8.00 (5.00, 10.00) | 0.152 |
| cKD/iKD | 145/137 | 132/127 | 13/10 | 0.609 |
| No. CAL | 59 (20.9%) | 53 (20.5%) | 6 (26.1%) | 0.525 |
| White blood cell, 109/L | 14.55 (11.26, 18.85) | 14.49 (11.20, 18.79) | 14.71 (11.31, 22.63) | 0.577 |
| Neutrophil count, 109/L | 8.42 (5.91, 11.31) | 8.13 (5.56, 11.14) | 9.76 (8.14, 15.78) | 0.009 |
| Lymphocyte count, 109/L | 4.50 (3.06, 6.05) | 4.63 (3.23, 6.16) | 2.60 (1.88, 3.34) | <0.001 |
| Hemoglobin, g/L | 101.02 ± 11.93 | 101.10 ± 11.99 | 100.13 ± 11.48 | 0.709 |
| Platelet count, 109/L | 402.00 (318.00, 513.00) | 404.00 (324.00, 518.00) | 324.00 (230.00, 484.00) | 0.028 |
| Mean platelet volume, fl | 9.70 (9.10, 10.30) | 9.70 (9.10, 10.30) | 9.60 (9.30, 10.60) | 0.628 |
| NLR | 1.93 (1.22, 2.90) | 1.79 (1.20, 2.61) | 4.86 (2.74, 6.26) | <0.001 |
| PLR | 94.59 (69.86, 125.14) | 91.29 (69.55, 121.59) | 132.74 (87.94, 198.08) | 0.006 |
| MPVLR | 2.14 (1.57, 3.24) | 2.07 (1.53, 3.00) | 3.64 (2.78, 5.21) | <0.001 |
| Alanine transaminase, IU/L | 24.00 (15.00, 42.00) | 23.00 (15.00, 40.00) | 33.00 (23.00, 45.00) | 0.057 |
| Serum albumin, g/L | 37.42 ± 4.42 | 37.68 ± 4.28 | 34.55 ± 5.03 | 0.001 |
| Serum sodium, mmol/L | 137.37 (135.50, 139.30) | 137.60 (135.68, 139.40) | 134.80 (133.21, 137.50) | 0.001 |
IVIG, intravenous immunoglobulin; cKD, complete Kawasaki disease; iKD, incomplete Kawasaki disease; No. CAL, numbers of coronary artery lesions; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; MPVLR, mean platelet volume-to-lymphocyte ratio.